Erica Hobson
Acute Care · Irvine, CANPI 1124652805
Payments from drug & device makers
$9,467in general payments, 2019–2025
Across 416 payments — averaging $22.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$832
- AstraZeneca$616
- E.r. Squibb & Sons, L.L.C.$577
- Pfizer$508
- Merck$472
- Incyte Corporation$466
- plus $6K from 54 others
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$9,467 in reported general payments places this provider in the 95th percentile of 1,153 acute care providers in California.
Other acute care in Irvine
- Mary AhmadianIrvine$6K
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Eleanor VierraSacramento$64K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.